Drupel Pharmaceutical Private Limited
About Drupel Pharmaceutical Private Limited
Data last updated:
Drupel Pharmaceutical Private Limited is a private limited company based in Gmc, Assam, India. It operates in the pharmaceutical retail and distribution segment of the pharmaceuticals sector. It was incorporated on 09 September 2019 and has been in existence for over 7 years.
The company is registered with the Registrar of Companies (ROC), Guwahati, under CIN U33110AS2019PTC019505. Its GSTIN is 18AAHCD4182C1ZS (Assam).
The company has an authorised share capital of ₹10 Lakh and a paid-up capital of ₹10,000. It is led by directors including Subir Ghosh and Sanjoy Ghosh.
Its last annual general meeting (AGM) was held on 29 September 2025, and its latest financial statements are for the year ended 31 March 2025. The registered office is at Gmc, Assam.
As per the financials filed for FY 2024, the company reported a revenue of ₹1.34 Cr, a growth of 8% compared to the previous year. For the same year it recorded a net profit of ₹4.43 Lakh (net margin 3.3%) and EBITDA of ₹8.3 Lakh (EBITDA margin 6.2%). Revenue has grown at a compounded annual rate (CAGR) of 49% over three years.
- EmailLocked
- TelephoneLocked
- WebsiteLocked
- Social MediaLocked
- Registered AddressHouse No. 37, Ramnagar Lokhra Road, Gmc, Assam, India – 781034
- IndustryPharma, Pharmaceutical Retailers & Distributors
- Company details, directors and signatories
- Historical financials and ratios
- Shareholding pattern and group structure
- Charges with holder and property details
- Legal cases, compliance and MCA filings
- One PDF report, delivered after checkout
Business Activity of Drupel Pharmaceutical Private Limited
The main business activity of Drupel Pharmaceutical is manufacturing. In detail, this covers chemical and chemical products, pharmaceuticals, medicinal chemical and botanical products.
| Main Activity Group Code | Description of Main Activity | Business Activity Code | Description of Business Activity | Turnover Percentage |
|---|---|---|---|---|
| C | Manufacturing | C6 | Chemical and chemical products, pharmaceuticals, medicinal chemical and botanical products | Locked |
Business activity turnover details
Turnover share and past changes in activity are in the company report.
- Turnover contribution
- Historical classifications
- Filing-level activity changes
Verified entity values are shown only after access is granted.
Financials of Drupel Pharmaceutical Private Limited FY 2025 filings available
Drupel Pharmaceutical Private Limited reported revenue of ₹1.34 Cr (up 8% YoY) for FY 2024.
Compounded Annual Growth Rate (CAGR) of Drupel Pharmaceutical Private Limited
Revenue has grown at a compounded annual rate (CAGR) of 49% over three years, including 8% growth in the latest year. EBITDA fell 2% in the latest year. Three- and five-year figures are compounded annual growth rates (CAGR): the steady yearly rate that links the first and the last year. All are worked out from the filed statements.
Financial Statement Summary of Drupel Pharmaceutical Private Limited
| Metrics | FY 2023-24 | FY 2022-23 | FY 2021-22 | FY 2020-21 | FY 2019-20 |
|---|---|---|---|---|---|
| Profit and Loss Statement | |||||
| Revenue from Operations | •••• | •••• | •••• | •••• | •••• |
| Other Income | •••• | •••• | •••• | •••• | •••• |
| Total Revenue | •••• | •••• | •••• | •••• | •••• |
| Cost of Materials Consumed | •••• | •••• | •••• | •••• | •••• |
| Employee Benefit Expense | •••• | •••• | •••• | •••• | •••• |
| Finance Costs | •••• | •••• | •••• | •••• | •••• |
| Depreciation and Amortisation | •••• | •••• | •••• | •••• | •••• |
| Other Expenses | •••• | •••• | •••• | •••• | •••• |
| Total Expenses | •••• | •••• | •••• | •••• | •••• |
| EBITDA | ₹8.3 Lakh | •••• | •••• | •••• | •••• |
| Profit Before Tax | •••• | •••• | •••• | •••• | •••• |
| Tax Expense | •••• | •••• | •••• | •••• | •••• |
| Net Profit (PAT) | ₹4.43 Lakh | •••• | •••• | •••• | •••• |
| Balance Sheet | |||||
| Share Capital | •••• | •••• | •••• | •••• | •••• |
| Reserves and Surplus | •••• | •••• | •••• | •••• | •••• |
| Net Worth (Total Equity) | •••• | •••• | •••• | •••• | •••• |
| Long-term Borrowings | •••• | •••• | •••• | •••• | •••• |
| Short-term Borrowings | •••• | •••• | •••• | •••• | •••• |
| Trade Payables | •••• | •••• | •••• | •••• | •••• |
| Total Liabilities | •••• | •••• | •••• | •••• | •••• |
| Fixed Assets | •••• | •••• | •••• | •••• | •••• |
| Investments | •••• | •••• | •••• | •••• | •••• |
| Inventories | •••• | •••• | •••• | •••• | •••• |
| Trade Receivables | •••• | •••• | •••• | •••• | •••• |
| Cash and Bank Balance | •••• | •••• | •••• | •••• | •••• |
| Total Assets | •••• | •••• | •••• | •••• | •••• |
Financial Ratios of Drupel Pharmaceutical Private Limited
| Metrics | FY 2023-24 | FY 2022-23 | FY 2021-22 | FY 2020-21 | FY 2019-20 |
|---|---|---|---|---|---|
| Profitability | |||||
| EBITDA Margin | 6.2% | •••• | •••• | •••• | •••• |
| Net Profit Margin | 3.3% | •••• | •••• | •••• | •••• |
| Return on Equity (ROE) | •••• | •••• | •••• | •••• | •••• |
| Return on Capital Employed (ROCE) | •••• | •••• | •••• | •••• | •••• |
| Return on Assets (ROA) | •••• | •••• | •••• | •••• | •••• |
| Liquidity and Debt | |||||
| Current Ratio | •••• | •••• | •••• | •••• | •••• |
| Quick Ratio | •••• | •••• | •••• | •••• | •••• |
| Debt-to-Equity Ratio | •••• | •••• | •••• | •••• | •••• |
| Interest Coverage Ratio | •••• | •••• | •••• | •••• | •••• |
| Efficiency and Growth | |||||
| Asset Turnover | •••• | •••• | •••• | •••• | •••• |
| Receivable Days | •••• | •••• | •••• | •••• | •••• |
| Payable Days | •••• | •••• | •••• | •••• | •••• |
| Inventory Days | •••• | •••• | •••• | •••• | •••• |
| Revenue Growth | •••• | •••• | •••• | •••• | •••• |
| Net Profit Growth | •••• | •••• | •••• | •••• | •••• |
Paid data: the figures shown as dots are available after purchase of the company report. Figures as filed with the MCA in Form AOC-4. The full year-wise statements and ratios of Drupel Pharmaceutical are in the company report.
Financial statements from FY 2020
Earlier years and trend charts are in the company report.
- Income statements
- Balance sheets
- Cash-flow statements
- Ratios and benchmarks
Verified entity values are shown only after access is granted.
Peer Comparison of Drupel Pharmaceutical Private Limited
Drupel Pharmaceutical Private Limited is compared with the companies closest to it by revenue in the same principal business activity (Chemical and chemical products, pharmaceuticals, medicinal chemical and botanical products). Net profit, margin and employee counts of each company are in the company report.
| Company | Revenue | Net profit | Margin | Growth (1 yr) | Employees | Location |
|---|---|---|---|---|---|---|
| Xania Healthcare Private Limited | ₹1.35 Cr (FY 2025) | •••• | •••• | 4.0% | •••• | Ahmedabad, Gujarat, India |
| Orbikem Private Limited | ₹1.35 Cr (FY 2023) | •••• | •••• | •••• | Kolkata, West Bengal, India | |
| Regenxgen Biosolutions Private Limited | ₹1.35 Cr (FY 2025) | •••• | •••• | 116.0% | •••• | Chennai, Tamil Nadu, India |
| GTK Bitumen Industries Private Limited | ₹1.35 Cr (FY 2025) | •••• | •••• | -25.0% | •••• | Bulandshahr, Uttar Pradesh, India |
| Mother's Care Pharma Laboratories Private Limited | ₹1.34 Cr (FY 2024) | •••• | •••• | 0.0% | •••• | Boudh, Odisha, India |
| Drupel Pharmaceutical Private Limited this company | ₹1.34 Cr (FY 2024) | •••• | •••• | 8.0% | •••• | Gmc, Assam, India |
| Alop Medi-Sciences Private Limited | ₹1.34 Cr (FY 2025) | •••• | •••• | 0.0% | •••• | Chennai, Tamil Nadu, India |
| Neorangic Healthcare Private Limited | ₹1.34 Cr (FY 2025) | •••• | •••• | 59.0% | •••• | Chandigarh, India |
| Riocure Pharmaceuticals Private Limited | ₹1.34 Cr (FY 2024) | •••• | •••• | 2.0% | •••• | Visakhapatnam, Andhra Pradesh, India |
| Speciochem Products Private Limited | ₹1.34 Cr (FY 2025) | •••• | •••• | -41.0% | •••• | Mumbai, Maharashtra, India |
| Preferntial Chemicals Private Limited | ₹1.34 Cr (FY 2025) | •••• | •••• | -11.0% | •••• | Vadodara, Gujarat, India |
Peers are the five companies nearest above and the five nearest below Drupel Pharmaceutical by revenue in the same principal business activity (Chemical and chemical products, pharmaceuticals, medicinal chemical and botanical products), from the latest filed financials of each company. Net profit, margin and employee counts of each peer are in the company report.
Board of Directors of Drupel Pharmaceutical Private Limited
Drupel Pharmaceutical has 4 directors on record. No former directors are listed.
| Name | Designation | Appointment Date | Tenure | Status |
|---|---|---|---|---|
| Subir Ghosh | Director | 09 Sep 2019 | 7 Years 1 Months | Current |
| Sanjoy Ghosh | Director | 01 Oct 2020 | 6 Years 0 Months | Current |
| Sujay Ghosh | Director | 01 Oct 2020 | 6 Years 0 Months | Current |
| Debajit Kar | Director | 09 Sep 2019 | 7 Years 1 Months | Current |
Ownership and Shareholding of Drupel Pharmaceutical Private Limited
Shareholding and ownership data
Promoter, institutional, public and beneficial ownership figures are in the company report.
- Ownership categories
- Historical changes
- Group structure
- FII and DII holdings
Verified entity values are shown only after access is granted.
Charges & Borrowings of Drupel Pharmaceutical Private Limited
Drupel Pharmaceutical Private Limited does not have any charges (loans) registered with the Registrar of Companies.
Employees and EPFO Compliance at Drupel Pharmaceutical Private Limited
Employment history and EPFO contributions of people linked to Drupel Pharmaceutical.
Employee and EPFO history
Monthly headcount, contribution history and filing status are in the company report.
- Monthly headcount
- PF contributions
- ECR filing status
- Establishment history
Verified entity values are shown only after access is granted.
Recent Activity on Drupel Pharmaceutical Private Limited
Drupel Pharmaceutical Private Limited has 4 board changes on record since 2019: 4 appointments. The latest: Sanjoy Ghosh was appointed as Director on 01 Oct 2020.
Credit Ratings, Litigation & Regulatory Alerts for Drupel Pharmaceutical Private Limited
Credit ratings, litigation, and regulatory alerts
Credit ratings, court records and regulatory alerts are in the company report.
- Rating history
- Court and tribunal cases
- Regulatory alerts
- Director-linked violations
Verified entity values are shown only after access is granted.
MSME Payment Delays by Drupel Pharmaceutical Private Limited
MSME payment history
Amounts due to small suppliers, the reasons given and MSME-1 filings are in the company report.
- Outstanding amounts
- Delay periods and reasons
- MSME-1 filing history
- Vendor payment signals
Verified entity values are shown only after access is granted.
Subsidiaries & Group Companies of Drupel Pharmaceutical Private Limited
Corporate group structure
Parent, subsidiary, associate and joint venture records with holdings are in the company report.
- Parent company
- Subsidiaries and ownership
- Associates and joint ventures
- Entity investments
Verified entity values are shown only after access is granted.
GST Compliance of Drupel Pharmaceutical Private Limited
Drupel Pharmaceutical has 1 GST registration: 1 active.
| GSTIN | State | Status | Registered on |
|---|---|---|---|
| 18AAHCD4182C1ZS | Assam | Active | 27 Sep 2019 |
GST registrations and filing compliance
State-wise GST registrations, return filing status and HSN or SAC codes are in the company report.
- GSTIN registrations
- State-wise filing status
- HSN and SAC details
- Tax jurisdiction records
Verified entity values are shown only after access is granted.
MCA Filings & Documents of Drupel Pharmaceutical Private Limited
MCA filings and documents
Filed forms, annual returns, financial statements and charge filings with their dates are in the company report.
- Incorporation documents
- Annual returns and statements
- Charge filings
- Complete filing index
Verified entity values are shown only after access is granted.
Frequently Asked Questions about Drupel Pharmaceutical Private Limited
Drupel Pharmaceutical is an active private limited company based in Gmc, Assam, India. The company works in pharmaceutical retailers and distributors, within the pharma industry. It was incorporated on 09 September 2019 (7+ years old) and is registered under CIN U33110AS2019PTC019505.
Drupel Pharmaceutical reported revenue of ₹1.34 Cr for FY 2024 (up 8% YoY).
Drupel Pharmaceutical has 4 current directors:
- Subir Ghosh - Director
- Sanjoy Ghosh - Director
- Sujay Ghosh - Director
- Debajit Kar - Director
Drupel Pharmaceutical reported a net profit of ₹4.43 Lakh (net margin 3.3%) and EBITDA of ₹8.3 Lakh (EBITDA margin 6.2%) for FY 2024, as per its filed financial statements.
The compounded annual growth rate (CAGR) of the revenue of Drupel Pharmaceutical is 49% over three years. In the latest year (FY 2024) revenue rose 8%. CAGR is the steady yearly rate that links the first and the last year.
The GSTIN of Drupel Pharmaceutical is 18AAHCD4182C1ZS, registered in Assam.
The CIN (Corporate Identification Number) of Drupel Pharmaceutical is U33110AS2019PTC019505. It is issued by the Ministry of Corporate Affairs under the Companies Act, 2013, and uniquely identifies the company in India.
Drupel Pharmaceutical was incorporated on 09 September 2019, making it 7+ years old. It is registered with the Registrar of Companies, Guwahati.
The peers of Drupel Pharmaceutical by revenue are Xania Healthcare Private Limited, Orbikem Private Limited, Regenxgen Biosolutions Private Limited, GTK Bitumen Industries Private Limited, Mother's Care Pharma Laboratories Private Limited and 5 more, all in the same principal business activity (Chemical and chemical products, pharmaceuticals, medicinal chemical and botanical products).
Sanjoy Ghosh was appointed as Director on 01 Oct 2020. Sujay Ghosh was appointed as Director on 01 Oct 2020. Debajit Kar was appointed as Director on 09 Sep 2019. Drupel Pharmaceutical has 4 board changes on record in total.
The registered office of Drupel Pharmaceutical is at House No. 37, Ramnagar Lokhra Road, Gmc, Assam, India – 781034.